Diagnosis of atrophic gastritis from a serum sample

Minerva Gastroenterologica e Dietologica

Volumn 49, Issue 1, 2003, Pages 11-21

  Sipponen, P ^a   Harkonen M ^b   Alanko, A ^c   Suovaniemi, O ^d  

^a JORVI HOSPITAL   (Finland)

^b Meilahti Hospital   (Finland)

^c Co Admin Board of Southern Finland ^*  (Finland)

^d Biohit Oyj   (Finland)

Author keywords

Gastritis, atrophic, diagnosis; Helicobacter pylori; Stomach neoplasms

Indexed keywords

BACTERIUM ANTIBODY; GASTRIN 17; PEPSINOGEN I;

ALGORITHM; ATROPHIC GASTRITIS; BLOOD SAMPLING; CANCER RISK; CYANOCOBALAMIN DEFICIENCY; DIAGNOSTIC PROCEDURE; EVIDENCE BASED MEDICINE; GASTRITIS; GASTROSCOPY; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; PEPTIC ULCER; REVIEW; SENSITIVITY ANALYSIS; STOMACH CANCER;

EID: 0037366263     PISSN: 00264776     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (40)

1. Siurala M, Lehtola J, Ihamäki T. Atrophic gastritis and its sequelae. Scand J Gastroenterol 1974;9:441-6.
2. Kekki M, Siurala M, Varis K, Sipponen P, Sistonen P, Nevanlinna H. Classification principles and genetic of chronic gastritis. Scand J Gastroenterol 1987;22:1-12.
3. Valle J, Kekki M, Sipponen P, Ihamäki T, Siurala M. Long-term course and zonsequences of Helicobacter pylori gastritis: Results of a 32-year follow-up study. Scand J Gastroenterol 1996;31:546-50.
4. Varis K. A family study of chronic gastritis. Scand J Gastroenterol 1971;6(Suppl. 13):1-56.
5. Varis O, Valle J, Siurala M. Is Helicobacter pylori involved in the pathogenesis of the chronic gastritis of pernicious anaemia: Comparison between pernicious anaemia relatives and duodenal ulcer relatives. Scand J Gastroenterol 1993;28:705-8.
6. Kokkola A, Rautelin H, Puolakkainen P, Sipponen P, Farkkila M, Haapiainen R et al. Diagnosis of Helicobacter pylori infection in patients with atrophic gastritis: comparison of histology, 13C-urea breath test, and serology. Scand J Gastroenterol 2000;35:138-41.
7. Roach ES, McLean WT. Neurologic disorders of vitamin B12 Deficiency. Am J Fam Physic 1982;25:111-5.
8. Varis K, Ihamäki T, Härkönen M, Samloff IM, Siurala M. Gastric morphology, function, and immunology in first-degree relatives of probands with pernicious anemia and controls. Scand J Gastroenterol 1979;14:129-39.
9. International Agency for Research on Cancer. Monographs on the Evaluation of Carcinogenic Risks to Humans. Infection with Helicobacter pylori. Lyon: IARC Scientific Publications, 1994;61:177-240.
10. Sipponen P, Seppälä K, Äärynen M, Helske T, Kettunen P. Chronic gastritis and gastroduodenal ulcer: a case control study of coexisting duodenal or gastric ulcer in patients with chronic gastritis. Gut 1989;30:922-9.
11. Sipponen P, Varis K, Fräki O, Korri UM, Seppälä K, Siurala M. Cumulative 10-year risk of symptomatic duodenal and gastric ulcer in patients with or without chronic gastritis. A clinical follow-up study of 454 out-patients. Scand J Gastroenterol 1990;25:966-73.
12. Varis K, Samloff IM, Ihamäki T, Siurala M. An appraisal of tests for severe atrophic gastritis in relatives of pernicious anemia. Dig Dis Sci 1979;24:187-91.
13. Borch K, Axelsson CK, Halgreen H, Damkjaer Nielsen MD, Ledin T, Szesci PB. The ratio of pepsinogen A to pepsinogen C: a sensitive test for atrophic gastritis. Scand J Gastroenterol 1989;24:870-6.
14. Miki K, Ichinose M, Ishikawa KB. Clinical application of serum pepsinogen I and II levels for mass screening to detect gastric cancer. Jpn J Cancer Res 1993;84:1086-90.
15. Miki K, Ichinose M, Shimizu A. Serum pepsinogens as a screening test of extensive chronic gastritis. Gastroenterol Jpn 1987;22:133-41.
16. Nomura AM, Stemmermann GN, Samloff IM. Serum pepsinogen I as a predictor of stomach cancer. Ann Intern Med 1980;93:537-40.
17. Yoshihara M, Sumii K, Haruma K. Correlation of ratio of serum pepsinogen I and II with prevalence of gastric cancer and adenoma in Japanese subjects. Am J Gastroenterol 1998;93:1090-6.
18. Kekki M, Samloff IM, Varis K, Ihamäki T. Serum pepsinogen serum and I gastrin in screening of severe atrophic corpus gastritis. Scand J Gastroenterol 1991;186:109-16.
19. Sipponen P, Kekki M, Haapakoski J, Ihamäki I, Siurala M. Gastric cancer risk in chronic atrophic gastritis: statistical calculations of cross-sectional data. Int J Cancer 1985;35:173-7.
20. Correa P. Human gastric carcinogenesis: Multistep and multifactorial process. Cancer Res 1992;52:6735-42.
21. Sjöblom SM, Sipponen P, Miettinen M, Karonen SL, Järvinen HJ. Gastroscopic screening for gastric carcinoids and carcinoma in perniscious anemia. Endoscopy 1988;20:52-6.
22. Varis K, Sipponen P, Laxén F. Implications of serum pepsinogen I in early endoscopic diagnosis of gastric cancer and dysplasia. Scand J Gastroenterol 2000;35:950-6.
23. Laxen F, Sipponen P, Härkönen M, Eskelinen R. Mahasyövän seulonnan arviointitutkimus. Seerumin pepsinogeen. In soveltuvuus ja taloudellisuus kahden kaupungin miesten mahasyövän seulonnassa. Suomen Terveystutkimus Oy, 1997.
24. Seppälä K, Pikkarainen P, Sipponen P, Kivilaakso E, Gormsen MH. Cure of peptic gastric ulcer associated with eradication of Helicobacterpylori. Finnish Gastric Ulcer Study Group. Gut 1995;36:834-7.
25. Clarke I, Smith AD, Jobst KA, Refsum H, Sutton L, Ueland PM. Folate, vitamin B12, and serum total homocysteine levels in confirmed Alzheimer disease. Arch Neurol 1998;55:1149-55.
26. Shevell MI, Rosenblatt DS. The neurology of cobolamin. Can J Neurol Sci 1992;19:472-86.
27. Regland B, Gottfries CG, Lindstedt G. Dementia patients with low serum cobolamnin concentration. Relationship to atrophic gastritis. Milano: Aging, 1992;4:35-41.
28. Yao Y, Yao SL, Yao SS, Yao G, Lou W. Prevalence of vitamin B12 deficiency among geriatric outpatients. J Fam Pract 1992;35:524-8.
29. Lindenbaum J, Healton EB, Savage DG. Neurologic diroders caused by cobolamin deficiency in the absence of anemia or macrocytosis. N Engl J Med 1988;318:1720-8.
30. Pitkänen J, Vilpo J. Voidaanko imeytymishäiriöstä johtuva B12-vitamiinin puutosta hoitaa oraalisilla valmisteilla? Suom Lääkäril 2001;56:1131-3.
31. Härkönen M, Nikulin M, Laxén F, Suovaniemi O, Sipponen P. Atrophic corpus gastritis raises the serum levels of homocysteine. Gastroenterol 2001;120(Suppl 1):A-241.
32. Welch GN, Loscalzo J. Homocysteine and atherothrombosis. N Engl J Med 1998;338:1042-50.
33. Varis K, Kekki M, Härkönen M, Sipponen P, Samloff IM. Serum pepsinogen I and serum gastrin in the screening of atrophic pangastritis with high risk of gastric cancer. Scand J Gastroenterol 1991;186:117-23.
34. Varis K, Taylor PR, Sipponen P and The Helsinki Study Group. Gastric cancer and premalignant lesions in atrophic gastritis. A controlled trial on the effect of supplementation with alpha-tocopherol and beta-carotene. Scand J Gastroenterol 1998;33:294-300.
35. Den Hartog G, Jansen JB, Schaardenburg DJ. Plasma gastrin responses to bombesin and antral gastrin concentrations in patients with the intestinal type gastric cancer. Cancer Res 1988;48:2296-8.
36. Sipponen P, Valle J, Varis K, Kekki M, Ihamäki T, Siurala M. Fasting levels of serum gastrin in different functional and morphological states of the antro-fundal mucosa. An analysis of 860 subjects. Scand J Gastroenterol 1990;25:513-9.
37. Hallissey MT, Dunn JA, Fielding JW. Evaluation of pepsinogen A and gastrin-17 as markers of gastric cancer and high-risk pathologic conditions. Scand J Gastroenterol 1994;29:1129-34.
38. Sipponen P, Ranta P, Helske T, Kääriäinen I, Mäki T, Linnala A et al. Serum levels of amidated gastrin-17 and pepsinogen I in atrophic gastritis. An observational case-control study. Scand J Gastroenterol 2002, in press.
39. Nicoli G, Zagari RM, Bozzato P, Lunedei V, DeLuca L, Antonini F et al. Diagnosis of atrophic gastritis based on combination of three non-invasibe tests: preliminary results of the Lojano-Monghidoro project. Dig Dis 2001;33(Suppl 1):A25.
40. The Danish Dyspepsia Study Group. Value of the unaided clinical diagnosis in dyspeptic patients in primary care. Am J Gastroenterol 2001;96:1417-21.